The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells

The histone methyltransferase EZH2 plays a role in maintenance of the stem component of cancer, and its overexpression and/or mutation typically drives tumor aggressiveness, drug resistance and patients’ poor prognosis. In this study, we use mouse and human medulloblastoma stem-like cells belonging...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Miele, Evelina, Valente, Sergio, Alfano, Vincenzo, Silvano, Marianna, Mellini, Paolo, Borovika, Diana, Marrocco, Biagina, Po, Agnese, Besharat, Zein Mersini, Catanzaro, Giuseppina, Battaglia, Giuseppe, Abballe, Luana, Zwergel, Clemens, Stazi, Giulia, Milite, Ciro, Castellano, Sabrina, Tafani, Marco, Trapencieris, Peteris, Mai, Antonello, Ferretti, Elisabetta
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2017
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5620277/
https://ncbi.nlm.nih.gov/pubmed/28978137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19782
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares